CRISPR-Based Diagnostics Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers Contributing to the Growth and Expansion of the CRISPR-Based Diagnostics Market?
The increase in occurrences of infectious diseases could stimulate the expansion of the CRISPR-based diagnostics market. Pathogenic microorganisms such as bacteria, viruses, fungi, or parasites cause these diseases, spread either directly or indirectly via food, water, contaminated surfaces, person to person, or by insect vectors. Factors contributing to the rise include globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and a lack of adequate healthcare access. CRISPR-based diagnostics aid in battling these diseases through swift and precise pathogen detection, which allows for prompt diagnosis, timely intervention, and successful containment measures. For instance, the UK Health Security Agency, an executive agency based in the UK, published data in August 2024 revealing that there were 368 measles cases in England in 2023, an almost seven-fold boost from the 53 cases in 2022. The West Midlands and London made up 44% and 33% of these cases, respectively. Consequently, the escalating incidence of infectious diseases is fueling the growth of the CRISPR-based diagnostics market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20734&type=smp
#What is the Projected CAGR for the CRISPR-Based Diagnostics Market Size from 2025 to 2034?
The market size of CRISPR-based diagnostics has seen a swift expansion in the recent past. It is projected to rise from $4.35 billion in 2024 to $5.14 billion in 2025, registering a compound annual growth rate (CAGR) of 18.1%. Factors that have contributed to growth during the historical period include an increase in healthcare spending, growing demand for gene editing, rising instances of chronic diseases, heightened awareness regarding treatment options and a higher occurrence of genetic diseases.
Expectations are high for the CRISPR-based diagnostics market, which is projected to experience a swift expansion over the next few years. Estimates suggest growth to $9.92 billion in 2029, with a compound annual growth rate (CAGR) of 17.9%. This anticipated growth throughout the forecast period is associated with factors such as the increasing need for fast and accurate diagnostics, amplified use in recognizing infectious diseases, government and institutional monetary support, improved identification of antibiotic resistance, and escalating acknowledgment and adoption of CRISPR technologies. Key trends set to impact the forecast period include point-of-care (POC) testing, CRISPR-Cas12 and Cas13 systems, personalized medicine and genetic screening, integration with nanotechnology and biosensors, and the employment of CRISPR for early disease detection.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20734
What New Market Trends Are Reshaping theCRISPR-Based Diagnostics Market and Its Opportunities?
Established enterprises in the CRISPR-based diagnostics sector are concentrating their efforts on forming strategic alliances to increase the availability of rapid and precise diagnostics via CRISPR-based point-of-care assessments. Strategic collaborations refer to enduring partnerships among multiple firms, pooling resources and know-how to realize shared objectives and boost their market standing. For instance, CrisprBits Private Limited, a biotech firm in India, declared their strategic partnership with Molbio Diagnostics, an India-origin molecular diagnostics firm, in August 2023. The aim of this cooperative effort is to develop CRISPR-based Point-of-Care Tests (POCTs). This partnership aspires to generate accurate, speedy, and cost-efficient diagnostic instruments, harnessing CRISPR technology to identify pathogens and genetic indicators. These POCTs strive to increase diagnostic access across various contexts, particularly in areas with limited resources, while guaranteeing timely and precise disease identification. This association amalgamates CrisprBits’ proficiency in CRISPR-laden platforms with Molbio’s production and distribution prowess to tap into the global market with these tests.
Who Are the Leading Market Players Fueling Growth in the CRISPR-Based Diagnostics Market Trend?
Major companies operating in the CRISPR-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., ToolGen Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/crispr-based-diagnostics-global-market-report
How is the Global CRISPR-Based Diagnostics Market Segemented?
The CRISPR-based diagnostics market covered in this report is segmented –
1) By Product: Kits, Buffer Solutions, Software, Other Products
2) By Technique: Recombinase Polymerase Amplification (RPA), Loop-mediated Isothermal Amplification (LAMP), Other Techniques
3) By Disease: Infectious Diseases, Non-Infectious Diseases
4) By End-User: Hospitals, Diagnostic Centers, Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Kits: CRISPR Detection Kits, CRISPR Amplification Kits, CRISPR-Based Assay Kits
2) By Buffer Solutions: CRISPR Reaction Buffers, CRISPR Lysis Buffers
3) By Software: CRISPR Data Analysis Software, CRISPR Design Software, CRISPR Diagnostic Platforms Software
4) By Other Products: CRISPR Enzymes, CRISPR Reagents, CRISPR-Based Probes
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20734&type=smp
Which Geographics are Influencing the Growth of the CRISPR-Based Diagnostics Market?
North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR-based diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global CRISPR-Based Diagnostics Market 2025, By The Business Research Company:
Medical And Diagnostic Laboratory Services Global Market Report 2025
Diagnostic Equipment Global Market Report 2025
https://thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report
Global Anesthesia And Respiratory Devices Opportunities And Strategies Global Global Market Report 2025
https://thebusinessresearchcompany.com/report/anesthesia-and-respiratory-devices-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
